Keywords: genzyme, reports, positive, results, second, pivotal, antithrombin

Genzyme reports positive results in second pivotal antithrombin III study

Article | 12 September 2000

Print This

A second Phase III trial of Genzyme General and Genzyme Transgenics'recombinant human antithrombin III has shown that the drug is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in